Pharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir in Healthy Chinese Subjects and HCV GT1b-Infected Chinese, South Korean and Taiwanese Patients

ConclusionCollectively, the results of these pharmacokinetic analyses support the use of the same dose of the 3D regimen for Asian and Western patients.Clinicaltrials.govNCT02534870, NCT02517515, NCT02517528.
Source: European Journal of Drug Metabolism and Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research